The global importance of such rare variants in tumorigenesis has been addressed by pan-cancer analysis, revealing significant enrichments for protein truncating variants in genes such as ATM, BRCA1/2, BRIP1, and MSH6 [11]. This evidence concerns the gene MSH6 and cancer.